The most commonly employed HCC biomarker, and the only one with phase 5 validation data, is AFP, but numerous other biomarkers (glypican-3, osteopontin, Golgi-protein 73, and PIVKA) have been, recently, reported [38]. The gene discussed is AFP; the disease is hepatocellular carcinoma.